Healthcare(4)

The Briefing keeps consultants ahead by unpacking essential trends and emerging questions they can answer through market research.

On this week’s issue: A US Supreme Court ruling upholds access to the abortion pill mifepristone. Medical trends are shifting toward work-life balance and holistic health. The Center for Medicare and Medicaid Services faces lawsuits amid regulatory changes. Insurance companies are rethinking their approach to costly weight loss drugs. Efforts to boost cybersecurity in rural hospitals are being made by both the government and tech companies.

The Briefing keeps consultants ahead by unpacking essential trends and emerging questions they can answer through market research.

On this week’s issue: Cybersecurity breaches in healthcare are causing multi-day outages. The DOJ is intensifying its focus on healthcare regulation with several investigations. Burnout remains widespread, especially among women in the industry. New weight loss drugs in development could soon improve obesity treatment accessibility. As AI adoption in healthcare grows, regulations are evolving to keep pace.

The Briefing keeps consultants ahead by unpacking essential trends and emerging questions they can answer through market research.

On this week’s issue: Healthcare providers are struggling after the Change Healthcare cyberattack. The Biden administration and CMS are updating Medicare and Medicaid regulations, requiring adjustments. Reproductive health legislation changes are under review. Financial challenges are causing layoffs in large healthcare organizations, while health tech startups are attracting institutional investors.

The Briefing keeps consultants ahead by unpacking essential trends and emerging questions they can answer through market research.

On this week’s issue: Cyberattacks have hit the US healthcare industry, prompting government action. Healthcare organizations are struggling with high turnover rates despite various solutions. Wearable tech for long-term care is popular but its effectiveness is questioned. Rising ADHD diagnoses are leading to research on medication side effects. Walgreens is divesting many VillageMD clinics, affecting community care.